Heron Bay Capital Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,177
Closed -$762K 71
2021
Q4
$762K Sell
3,177
-1,379
-30% -$355K 0.38% 53
2021
Q3
$1.29M Buy
4,556
+69
+2% +$22.6K 0.67% 48
2021
Q2
$1.55M Sell
4,487
-2,765
-38% -$838K 0.86% 41
2021
Q1
$2.03M Buy
7,252
+1,042
+17% +$281K 1.21% 33
2020
Q4
$1.52M Buy
+6,210
New +$1.6M 0.99% 38

Other funds holding BIIB

Heron Bay Capital Management's BIIB Position: Q1 2022 in Review

Heron Bay Capital Management sold out of Biogen (BIIB) in Q1 2022, closing a stake of 3,177 shares — an estimated $762K sold.

Heron Bay Capital Management first reported a position in BIIB in Q4 2020 and held it in 5 quarters. The position peaked at $2.03M in Q1 2021. 952 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

  • Heron Bay Capital Management reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
  • Heron Bay Capital Management sold 3,177 Biogen shares in Q1 2022, an estimated $762K.
  • Heron Bay Capital Management first reported a position in Biogen in Q4 2020 and held it in 5 quarters.
  • Heron Bay Capital Management's Biogen position peaked at $2.03M in Q1 2021.
  • 952 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on Heron Bay Capital Management's 13F filing for Q1 2022, filed 16 May 2022.